From: Pharmacokinetics, radiation dosimetry, acute toxicity and automated synthesis of [18F]AmBF3-TATE
Target organ | [18F]AmBF3-TATE | [68Ga]Ga-DOTA-TATE* | |
---|---|---|---|
Female | Male | ||
Adrenals | 5.87E−03 | 4.84E−03 | 1.46E−02 |
Brain | 1.62E−04 | 1.61E−04 | 9.86E−03 |
Breast | 7.73E−04 | – | 9.96E−03 |
Esophagus | 2.10E−03 | 1.57E−03 | – |
Eye | 2.43E−04 | 3.08E−04 | – |
Gallbladder wall | 5.49E−03 | 3.68E−03 | 1.49E−02 |
Left colon | 6.29E−03 | 6.71E−03 | 1.29E−02 |
Small intestine | 8.43E−03 | 6.20E−03 | 1.38E−02 |
Stomach wall | 1.18E−02 | 8.14E−03 | 1.38E−02 |
Right colon | 4.29E−03 | 3.68E−03 | 1.29E−02 |
Rectum | 5.91E−03 | 4.22E−03 | – |
Heart | 2.81E−03 | 2.08E−03 | 1.23E−02 |
Kidneys | 6.69E−03 | 4.78E−03 | 9.21E−02 |
Liver | 2.33E−03 | 1.74E−03 | 4.50E−02 |
Lungs | 1.27E−02 | 6.25E−03 | 1.15E−02 |
Ovaries | 2.45E−03 | – | 1.31E−02 |
Pancreas | 2.80E−02 | 1.81E−02 | 1.67E−02 |
Prostate | – | 2.66E−03 | – |
Salivary glands | 7.32E−04 | 9.24E−04 | 1.17E-02 |
Red marrow | 1.28E−03 | 1.02E−03 | 9.61E−03 |
Skeleton | 7.92E−04 | 7.13E−04 | 1.55E−02 |
Spleen | 3.19E−03 | 2.07E−03 | 2.82E−01 |
Testes | – | 1.11E−03 | 1.12E−02 |
Thymus | 6.08E−03 | 4.20E−03 | 1.09E−02 |
Thyroid | 1.99E−03 | 1.66E−03 | 1.87E−02 |
Urinary bladder | 2.67E−02 | 3.02E−02 | 1.25E−01 |
Uterus | 4.50E−03 | – | 1.47E−02# |
Remainder of body | 1.49E−03 | 1.04E−03 | 1.34E−02 |
Effective dose | 5.91E−03 | 4.36E−03 | 2.57E−02 |